Acceleration of Bcr-Abl(+) leukemia induced by deletion of JAK2

por Grundschober, E, Hoelbl-Kovacic, A, Bhagwat, N, Kovacic, B, Scheicher, R, Eckelhart, E, Kollmann, K, Keller, M, Grebien, F, Wagner, K-U, Levine, R L, Sexl, V
Publicado 2014

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

por Tefferi, A, Abdel-Wahab, O, Cervantes, F, Crispino, J D, Finazzi, G, Girodon, F, Gisslinger, H, Gotlib, J, Kiladjian, J-J, Levine, R L, Licht, J D, Mullally, A, Odenike, O, Pardanani, A, Silver, R T, Solary, E, Mughal, T
Publicado 2011

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

por Tefferi, A, Lasho, T L, Abdel-Wahab, O, Guglielmelli, P, Patel, J, Caramazza, D, Pieri, L, Finke, C M, Kilpivaara, O, Wadleigh, M, Mai, M, McClure, R F, Gilliland, D G, Levine, R L, Pardanani, A, Vannucchi, A M
Publicado 2010

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

por Kämpjärvi, K, Mäkinen, N, Kilpivaara, O, Arola, J, Heinonen, H-R, Böhm, J, Abdel-Wahab, O, Lehtonen, H J, Pelttari, L M, Mehine, M, Schrewe, H, Nevanlinna, H, Levine, R L, Hokland, P, Böhling, T, Mecklin, J-P, Bützow, R, Aaltonen, L A, Vahteristo, P
Publicado 2012